Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
mNEXSPIKE has been authorized in the EU since February 2026; the official EMA website describes it as an mRNA COVID-19 vaccine. mNEXSPIKE ist seit Februar 2026 in der EU zugelassen; die offizielle EMA-Seite beschreibt es als mRNA-COVID-19-Impfstoff.